Smoldering multiple myeloma Trials in Boston, United States
Conditions / Smoldering multiple myeloma / Boston, United States
Smoldering multiple myeloma has been the subject of sustained clinical investigation across multiple research sites.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03301220 | A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00114101 | Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant | ACTIVE_NOT_RECRUITING | — |
| NCT01177527 | Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders | ACTIVE_NOT_RECRUITING | — |
| NCT02269592 | Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome | RECRUITING | — |
| NCT01169337 | Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma | ACTIVE_NOT_RECRUITING | — |
| NCT00114101 | Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant | ACTIVE_NOT_RECRUITING | — |
| NCT05469893 | Immuno-PRISM (PRecision Intervention Smoldering Myeloma) | RECRUITING | PHASE2 |
| NCT05767359 | CAR- PRISM (PRecision Intervention Smoldering Myeloma) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT01302886 | Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma | COMPLETED | PHASE2 |
| NCT06365060 | Screening for AL Amyloidosis in Smoldering Multiple Myeloma | RECRUITING | — |